Clinical activity of cabozantinib in patients with advanced hepatocellular carcinoma previously treated with anti-VEGF and immuno-oncology therapy: subgroup analysis from the phase 3 CELESTIAL trial

J. Trojan, G. K. Abou-Alfa, A. -L. Cheng, S. Saletan,R. K. Kelley,A. B. El-Khoueiry

ONCOLOGY RESEARCH AND TREATMENT(2020)

引用 0|浏览0
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要